Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978715 · ClinicalTrials.gov registry record
The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT03978715 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 3,000 participants.
The verdict
NCT03978715 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The investigators plan to do a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investigators will collect information on demographics, medical/surgical history, social history, medications, laboratory results, peripheral arterial disease, wound severity, and treatment factors such as type of antibiotics, off-loading, debridement, wound healing, surgery interventions, complications, recurrence, and history and physical characteristics and exam from inpatient and outpatient encounters. This will be identified by current procedural terminology (CPT) codes for foot and leg amputations, and lower extremity revascularization procedures. Clinic visits will be identified to podiatry/foot wound, vascular surgery, invasive cardiology, general surgery, and physical therapy wound care in addition to inpatient encounters of these patients to determine the full scope of care received and to compare resources utilization before and after implementation of the diabetic limb preservation team.
Interventions
- OTHER No intervention-retrospective study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2022-10-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978715
The ClinicalTrials.gov registry entry for NCT03978715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention-retrospective study is the first listed.
NCT03978715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978715 about?
NCT03978715 is a clinical study titled "The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates". The investigators plan to do a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investigators will collect information on dem...
What is the current status of trial NCT03978715?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2021-04-14. Estimated completion is 2022-10-07.
What interventions are being tested in trial NCT03978715?
The interventions under investigation include: No intervention-retrospective study (OTHER).
Who is sponsoring clinical trial NCT03978715?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.